Author: Emily Smith
-
Amgen, a biotechnology company that has carved out a significant place in the pharmaceutical landscape, is now attempting to challenge industry giants Eli Lilly and Novo Nordisk in the GLP-1 space. With a new experimental obesity drug in the works, Amgen aims to provide an alternative for millions of patients seeking effective weight loss solutions.…
-
MicroStrategy (MSTR) is once again making waves, but this time it’s a story of ups and downs. The analytics and software company, best known for its massive Bitcoin holdings, faced a turbulent market day following a mix of big announcements and controversial market maneuvers. Below, we break down the key events that are driving the…
-
The upcoming trading session is set to be an eventful one, with several major factors likely to shape market movements. From corporate earnings reports to crucial economic data releases, and potential Federal Reserve announcements, investors have plenty to keep an eye on. Let’s take a closer look at the key developments that could influence the…